- Home
- NRIX vs GRC Comparison
NRIX vs GRC Comparison
Compare NRIX & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | GRC |
|---|---|---|
| Founded | 2009 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NRIX | GRC |
|---|---|---|
| Price | $25.65 | $72.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $30.50 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 128.1K |
| Earning Date | 04-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | N/A | ★ 32.03 |
| EPS | N/A | ★ 1.41 |
| Revenue | $76,987,000.00 | ★ $682,389,000.00 |
| Revenue This Year | N/A | $6.62 |
| Revenue Next Year | $48.05 | $4.66 |
| P/E Ratio | ★ N/A | $51.68 |
| Revenue Growth | ★ 99.31 | 3.44 |
| 52 Week Low | $8.20 | $42.31 |
| 52 Week High | $28.23 | $92.78 |
Technical Indicators
Market Signals| Indicator | NRIX | GRC |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | N/A |
| Support Level | $24.95 | N/A |
| Resistance Level | $28.23 | N/A |
| Average True Range (ATR) | 1.02 | 0.00 |
| MACD | -0.16 | 0.00 |
| Stochastic Oscillator | 40.83 | 0.00 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of its revenue from the United States.